Literature DB >> 265525

Pterin-6-aldehyde, a cancer cell catabolite: identification and application in diagnosis and treatment of human cancer.

R Halpern, B C Halpern, B Stea, A Dunlap, K Conklin, B Clark, H Ashe, L Sperling, J A Halpern, D Hardy, R A Smith.   

Abstract

Active folic acid degradation with the formation pterin-6-aldehyde is a previously undescribed characteristic of cancer cells in tissue culture. Neither normal adult epithelial and fibroblastic cells nor human amniotic cells nor mouse embryonic fibroblasts degrade folic acid to a measurable degree. Twenty-nine patients whose diagnoses were not revealed until after the test of their first morning urine for pterin-6-aldehyde was completed were studied for the presence or absence of pterin-6-aldehyde by thin-layer chromatography. Pterin-6-aldehyde was found in the urine at about 300 nmol/ml or greater only in those 13 patients with a tissue diagnosis of cancer. When the cancer was totally resected, the pterin-6-aldehyde was no longer found in the urine postoperatively. Pterin-6-aldehyde is not found in the urine of healthy patients at this level of detection unless their diets are supplemented with folic acid.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 265525      PMCID: PMC392336          DOI: 10.1073/pnas.74.2.587

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  9 in total

1.  The metabolism of tritiated folic acid in man.

Authors:  D G JOHNS; S SPERTI; A S BURGEN
Journal:  J Clin Invest       Date:  1961-09       Impact factor: 14.808

2.  Enzymic cleavage of folic acid by extracts from human blood cells. I. Preparation and co-factor requirements of the enzyme system.

Authors:  B M BRAGANCA; I ARAVINDAKSHAN; D S GHANEKAR
Journal:  Biochim Biophys Acta       Date:  1957-09

3.  Some observations on the oxidative degradation of pteroyl-L-glutamic acid.

Authors:  J A BLAIR
Journal:  Biochem J       Date:  1957-02       Impact factor: 3.857

4.  Isolation of isoxanthopterin from human urine.

Authors:  J A BLAIR
Journal:  Biochem J       Date:  1958-03       Impact factor: 3.857

5.  The metabolic conversion of folic acid and citrovorum factor to a diazotizable amine.

Authors:  B ALLEN; P L DAY; J S DINNING; J T SIME; P S WORK
Journal:  Arch Biochem Biophys       Date:  1957-01       Impact factor: 4.013

6.  The inactivation of folic acid by liver.

Authors:  S FUTTERMAN; M SILVERMAN
Journal:  J Biol Chem       Date:  1957-01       Impact factor: 5.157

7.  THE PRODUCTION OF FOLIC ACID BY RAT LIVER IN VITRO.

Authors:  L D Wright; A D Welch
Journal:  Science       Date:  1943-08-20       Impact factor: 47.728

8.  Pterins in human urine.

Authors:  T Fukushima; T Shiota
Journal:  J Biol Chem       Date:  1972-07-25       Impact factor: 5.157

9.  Biosynthesis of pteridines in the tadpole of the bullfrog, Rana catesbeiana.

Authors:  T Fukushima
Journal:  Arch Biochem Biophys       Date:  1970-08       Impact factor: 4.013

  9 in total
  8 in total

Review 1.  Urinary unconjugated pteridines: general considerations.

Authors:  B Stea; R A Smith
Journal:  Surv Immunol Res       Date:  1982

2.  Simultaneous determination of xanthopterin and isoxanthopterin in human urine by synchronous fluorescence spectroscopy.

Authors:  Yi-Qun Wan; Li-Juan Tang; Ting Tan
Journal:  J Fluoresc       Date:  2010-04-24       Impact factor: 2.217

3.  Establishing pteridine metabolism in a progressive isogenic breast cancer cell model.

Authors:  Lindsey Rasmussen; Zachary Foulks; Casey Burton; Honglan Shi
Journal:  Metabolomics       Date:  2021-12-17       Impact factor: 4.290

4.  Biopterin level in blood cells as a marker for hemopoietic cell proliferation during autologous bone marrow transplantation in beagle dogs.

Authors:  I Ziegler; H J Kolb; U Bodenberger; W Wilmanns
Journal:  Blut       Date:  1982-05

5.  Differential calcium leucovorin protection of human lymphoid cell lines from methotrexate.

Authors:  G P Browman; L Booker; P Spiegl
Journal:  Cancer Chemother Pharmacol       Date:  1985       Impact factor: 3.333

6.  Mechanism of Substrate and Inhibitor Binding of Rhodobacter capsulatus Xanthine Dehydrogenase.

Authors:  Uwe Dietzel; Jochen Kuper; Jennifer A Doebbler; Antje Schulte; James J Truglio; Silke Leimkühler; Caroline Kisker
Journal:  J Biol Chem       Date:  2008-12-24       Impact factor: 5.157

7.  A survey of some active sheep pineal fractions and a discussion on the possible significance of pteridines in those fractions in in vitro and in vivo assays.

Authors:  I Ebels; A de Morée; A Hus-Citharel; A Moszkowska
Journal:  J Neural Transm       Date:  1979       Impact factor: 3.575

8.  Effect of an implanted Walker tumour on metabolism of folic acid in the rat.

Authors:  P A Barford; J A Blair
Journal:  Br J Cancer       Date:  1978-07       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.